Taken together, we have uncovered a mechanism in human ovarian cancer that FBN1, stimulated by Aur A but inhibited by BRCA2, promotes ovarian cancer metastasis possibly through the p53 and SLUG-associated signaling (Figure 7), which may provide some novel insights to improve ovarian cancer diagnosis and treatment. The gene discussed is BRCA2; the disease is ovarian carcinoma.